bluebird bio Statistics

Total Valuation

bluebird bio has a market cap or net worth of $3.59 million. The enterprise value is $3.35 million.

Market Cap	3.59M
Enterprise Value	3.35M

Important Dates

The next confirmed earnings date is Thursday, August 28, 2025, after market close.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

bluebird bio has 97.40 million shares outstanding. The number of shares has increased by 44.02% in one year.

Current Share Class	97.40M
Shares Outstanding	97.40M
Shares Change (YoY)	+44.02%
Shares Change (QoQ)	-15.99%
Owned by Insiders (%)	25.88%
Owned by Institutions (%)	3.99%
Float	65.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	0.20
PB Ratio	-44.98
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.06
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.97

Financial Position

The company has a current ratio of 0.87

Current Ratio	0.87
Quick Ratio	0.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6,729.39% and return on invested capital (ROIC) is -4,687.94%.

Return on Equity (ROE)	-6,729.39%
Return on Assets (ROA)	-160.13%
Return on Invested Capital (ROIC)	-4,687.94%
Return on Capital Employed (ROCE)	1,533.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	248
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, bluebird bio has paid $9,481 in taxes.

Income Tax	9,481
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.49% in the last 52 weeks. The beta is 0.03, so bluebird bio's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-72.49%
50-Day Moving Average	4.42
200-Day Moving Average	7.51
Relative Strength Index (RSI)	62.84
Average Volume (20 Days)	1,050,643

Short Selling Information

The latest short interest is 281,482, so 2.87% of the outstanding shares have been sold short.

Short Interest	281,482
Short Previous Month	428,147
Short % of Shares Out	2.87%
Short % of Float	2.89%
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.22M
Pretax Income	-1.09M
Net Income	-1.10M
EBITDA	n/a
EBIT	-1.22M
Earnings Per Share (EPS)	-$0.02

Full Income Statement

Balance Sheet

The company has $221,221 in cash and n/a in debt, giving a net cash position of $221,221 or $0.00 per share.

Cash & Cash Equivalents	221,221
Total Debt	n/a
Net Cash	221,221
Net Cash Per Share	$0.00
Equity (Book Value)	-79,724
Book Value Per Share	-0.00
Working Capital	-79,724

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.14 million and capital expenditures $10,436, giving a free cash flow of -$1.13 million.

Operating Cash Flow	-1.14M
Capital Expenditures	10,436
Free Cash Flow	-1.13M
FCF Per Share	-$0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

bluebird bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.02%
Shareholder Yield	-44.02%
Earnings Yield	-30.58%
FCF Yield	-31.52%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	797.38%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (5Y)	48.63%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 20, 2023. It was a reverse split with a ratio of 0.212766.

Last Split Date	Jan 20, 2023
Split Type	Reverse
Split Ratio	0.212766

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a